Clinical trial
Efficacy and Safety of Tetrabenazine in Chorea
NCT00219804 · Prestwick Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00219804 |
|---|---|
| Title | Efficacy and Safety of Tetrabenazine in Chorea |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of Tetrabenazine for the Treatment of Huntington's Chorea |
| Lead sponsor | Prestwick Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Huntington's Disease |
| Intervention type | Drug |
| Interventions | tetrabenazine or placebo |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: